Skip to main content
Journal cover image

The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger.

Publication ,  Journal Article
Han, CH; Lu, J; Wei, Q; Bondy, ML; Brewster, AM; Yu, T-K; Buchholz, TA; Arun, BK; Wang, L-E
Published in: Breast Cancer Res Treat
July 2010

PIN1, an isomerase that causes conformational changes in proteins, plays an important role in mammary epithelial cell growth both physiologically and pathologically. Thus, genetic variants in the PIN1 gene may alter protein function and cancer risk. We have previously demonstrated an association between a PIN1 promoter variant (-842G>C; rs2233678) and risk of squamous cell carcinoma of the head and neck, a finding supported by additional functional data. In the present study, we genotyped two promoter single nucleotide polymorphisms (SNPs) (-842G>C, rs2233678 and -667T>C, rs2233679) and one synonymous SNP (Gln33Gln; G>A, rs2233682) in exon 2 to evaluate their associations with risk of sporadic breast cancer in non-Hispanic white women 55 years and younger. We found that the carriers of -842C variant alleles had decreased risk of breast cancer with an adjusted odd ratio (OR) of 0.67 and 95% confidence interval (CI) of 0.50-0.90. This reduced risk was more evident in women after reproductive age of 45 (OR = 0.63, 95% CI = 0.42-0.93), ever-smokers (OR = 0.56, 95% CI = 0.36-0.88), and ever-drinkers (OR = 0.67, 95% CI = 0.45-0.99). No such associations were observed for PIN1 -667T>C and PIN1 Gln33Gln. However, the haplotypes of these three SNPs were also associated with reduced risk of breast cancer. In conclusion, the PIN1 polymorphisms may contribute to the etiology of sporadic breast cancer in non-Hispanic white women 55 years and younger. Further validation in large population-based studies is needed.

Duke Scholars

Published In

Breast Cancer Res Treat

DOI

EISSN

1573-7217

Publication Date

July 2010

Volume

122

Issue

1

Start / End Page

243 / 249

Location

Netherlands

Related Subject Headings

  • White People
  • Smoking
  • Risk
  • Polymorphism, Single Nucleotide
  • Polymorphism, Genetic
  • Peptidylprolyl Isomerase
  • Oncology & Carcinogenesis
  • NIMA-Interacting Peptidylprolyl Isomerase
  • Middle Aged
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Han, C. H., Lu, J., Wei, Q., Bondy, M. L., Brewster, A. M., Yu, T.-K., … Wang, L.-E. (2010). The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger. Breast Cancer Res Treat, 122(1), 243–249. https://doi.org/10.1007/s10549-009-0682-9
Han, Chan H., Jiachun Lu, Qingyi Wei, Melissa L. Bondy, Abenaa M. Brewster, Tse-Kuan Yu, Thomas A. Buchholz, Banu K. Arun, and Li-E Wang. “The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger.Breast Cancer Res Treat 122, no. 1 (July 2010): 243–49. https://doi.org/10.1007/s10549-009-0682-9.
Han, Chan H., et al. “The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger.Breast Cancer Res Treat, vol. 122, no. 1, July 2010, pp. 243–49. Pubmed, doi:10.1007/s10549-009-0682-9.
Han CH, Lu J, Wei Q, Bondy ML, Brewster AM, Yu T-K, Buchholz TA, Arun BK, Wang L-E. The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger. Breast Cancer Res Treat. 2010 Jul;122(1):243–249.
Journal cover image

Published In

Breast Cancer Res Treat

DOI

EISSN

1573-7217

Publication Date

July 2010

Volume

122

Issue

1

Start / End Page

243 / 249

Location

Netherlands

Related Subject Headings

  • White People
  • Smoking
  • Risk
  • Polymorphism, Single Nucleotide
  • Polymorphism, Genetic
  • Peptidylprolyl Isomerase
  • Oncology & Carcinogenesis
  • NIMA-Interacting Peptidylprolyl Isomerase
  • Middle Aged
  • Humans